|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 07/15/07 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 29/15/29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 0 | ||
| +0.65% | -3.36% | +36.98% | +60.50% | 6.35TCr | ||
| +1.76% | +1.27% | +11.82% | +81.21% | 5.45TCr | ||
| -0.94% | +0.99% | +10.45% | +100.19% | 5.36TCr | ||
| +2.76% | +0.87% | +27.92% | +55.07% | 4.48TCr | ||
| +2.00% | -3.39% | +17.83% | +119.04% | 4.16TCr | ||
| +1.34% | -2.86% | +224.43% | +914.08% | 3.99TCr | ||
| +0.64% | -3.95% | +11.15% | +45.57% | 3.25TCr | ||
| +29.06% | +47.63% | +107.12% | +92.73% | 2.67TCr | ||
| +3.72% | -6.23% | +26.01% | -2.99% | 2.34TCr | ||
| Average | +4.55% | -0.42% | +52.63% | +162.82% | 3.8TCr | |
| Weighted average by Cap. | +3.23% | -0.29% | +48.19% | +161.47% |
Historical Quotes: Pharmacyclics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- Stock
- Quotes Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















